(Q48704507)

14 February 2018

title

An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease. (English)

1 reference

14 February 2018

1 reference

1 reference

1

1 reference

14 February 2018

author name string

Hattori N

2

1 reference

14 February 2018

Mori H

3

1 reference

14 February 2018

Kato K

4

1 reference

14 February 2018

Mizuno Y

5

1 reference

14 February 2018

publication date

1 May 1997

1 reference

14 February 2018

Journal of the Neurological Sciences

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 February 2018

volume

148

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

181-186

1 reference

14 February 2018

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Sensitive enzyme immunoassay for human Mn superoxide dismutase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Free radicals and myocardial ischemia: overview and outlook

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Parkinson's disease: a disorder due to nigral glutathione deficiency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Superoxide dismutase expression in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905339-7

10.1016/S0022-510X(96)05339-7

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018